These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12580870)

  • 21. Fractal analysis of the effects on mandibular bone of botulinum toxin therapy of the masseter muscle in patients with bruxism.
    Polat Balkan E; Paksoy CS; Bağış N
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Jan; 137(1):83-88. PubMed ID: 37805341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical practice of botulinum toxin treatment in oral and maxillofacial field].
    Xie Y; Fu KY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Feb; 45(2):124-6. PubMed ID: 20368010
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
    Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
    Pullman SL; Greene P; Fahn S; Pedersen SF
    Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Masseter Muscle and Its Role in Facial Contouring, Aging, and Quality of Life: A Literature Review.
    Almukhtar RM; Fabi SG
    Plast Reconstr Surg; 2019 Jan; 143(1):39e-48e. PubMed ID: 30303926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Botulinum toxins for pain].
    Soinila S; Haanpää M
    Duodecim; 2011; 127(22):2425-30. PubMed ID: 22238920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does botulinum toxin have any role in the management of chronic pain associated with bruxism?
    M Alwayli H; Abdulrahman BI; Rastogi S
    Cranio; 2024 Mar; 42(2):215-222. PubMed ID: 34259618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of bruxism in Huntington's disease with botulinum toxin.
    Nash MC; Ferrell RB; Lombardo MA; Williams RB
    J Neuropsychiatry Clin Neurosci; 2004; 16(3):381-2. PubMed ID: 15377749
    [No Abstract]   [Full Text] [Related]  

  • 29. Botulinum toxin type A for controlling bruxism assessed with computerized occlusal analysis: A pilot study.
    Pardo NB; Kerstein RB; Júnior MC; Ferreira LS; Abrahão M
    Cranio; 2022 May; 40(3):207-216. PubMed ID: 32122286
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of botulinum toxin therapy in treatment of myofascial pain.
    Chaurand J; Pacheco-Ruíz L; Orozco-Saldívar H; López-Valdés J
    J Oral Sci; 2017; 59(3):351-356. PubMed ID: 28904310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bruxism after brain injury: successful treatment with botulinum toxin-A.
    Ivanhoe CB; Lai JM; Francisco GE
    Arch Phys Med Rehabil; 1997 Nov; 78(11):1272-3. PubMed ID: 9365360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of botulinum toxin for grinding in patients with Rett syndrome-Case report.
    Komisarek O; Malak R; Śledzińska A; Śledzińska P; Mojs E; Matthews-Kozanecka M; Samborski W
    Spec Care Dentist; 2024; 44(3):737-742. PubMed ID: 37608434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX - A)for treatment of temporomandibular disorder.
    Zhang LD; Liu Q; Zou DR; Yu LF
    Br J Oral Maxillofac Surg; 2016 Sep; 54(7):736-40. PubMed ID: 27138229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Evaluation of the Clinical Effects of Botulinum Toxin on Nocturnal Bruxism.
    Asutay F; Atalay Y; Asutay H; Acar AH
    Pain Res Manag; 2017; 2017():6264146. PubMed ID: 28757802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on new and unique uses of botulinum toxin in movement disorders.
    Jankovic J
    Toxicon; 2018 Jun; 147():84-88. PubMed ID: 28888928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin in movement disorders.
    Jankovic J
    Curr Opin Neurol; 1994 Aug; 7(4):358-66. PubMed ID: 7952246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease-oriented approach to botulinum toxin use.
    Jankovic J
    Toxicon; 2009 Oct; 54(5):614-23. PubMed ID: 19073203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial.
    Lee SJ; McCall WD; Kim YK; Chung SC; Chung JW
    Am J Phys Med Rehabil; 2010 Jan; 89(1):16-23. PubMed ID: 19855255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of onabotulinumtoxinA in post-traumatic oromandibular dystonia.
    Pedemonte C; Pérez Gutiérrez H; González E; Vargas I; Lazo D
    J Oral Maxillofac Surg; 2015 Jan; 73(1):152-7. PubMed ID: 25315313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of botulinum toxin injections on bruxism: A systematic review.
    Ågren M; Sahin C; Pettersson M
    J Oral Rehabil; 2020 Mar; 47(3):395-402. PubMed ID: 31769044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.